Answers are grounded in this paper and cite their sources.
The copper(II) complex of a novel rhodamine-azamacrocycle conjugate binds to the CXCR4 chemokine receptor and competes effectively against anti-CXCR4 monoclonal antibodies. The copper macrocycle unit adopts a trans-II configuration in the solid state.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: